Skip to main content
ROVI Subsidiaries
Spain
Germany
France
Italy
Poland
Portugal
United Kingdom
Language
Spanish
Spanish
English
English
English
Español
Home
ROVI
History
Group structure
Business units
International expansion
Strategy
Licenses
Contact
Products
Prescription Pharmaceuticals
Hospital Products
Manufacturing
CDMO
Own product Manufacturing
R&D
Shareholders and Investors
The share
Investor's Calendar
News
Financial and Business Information
CMNV Communications
ESG
Corporate Governance
Telematic assistance access
Prior Registration On-Line Attendance
On-Line Attendance
Sustainability
Responsible governance
Commitment to people
Environmental Commitment
Ethics Channel
Media
FAQS
News
ROVI up to date
Contact
Work with Us
TELEMATIC ASSISTANCE ACCESS
Home
News
Full Year 2019 results presentation
Operating income, growth figures, profitability and how our products have behaved
Wed, 26/02/2020 - 00:00
0 min
Español
Pantallazos-ROVI-4-1024x576(1).jpg
Download related document
Select rating
Give Full Year 2019 results presentation 1/5
Give Full Year 2019 results presentation 2/5
Give Full Year 2019 results presentation 3/5
Give Full Year 2019 results presentation 4/5
Give Full Year 2019 results presentation 5/5
No votes yet
Related
First nine months 2023 results press release
ROVI REPORTS OPERATING REVENUE GROWTH OF 3% FOR THE FIRST NINE MONTHS OF THE FIRST POST-PANDEMIC YEAR Operating revenue increased 3%...
5 min
08/11/2023
ROVI takes first place in the Sustainalytics world ESG risk ranking for the...
ROVI takes first place in the Sustainalytics world ESG risk ranking for the second year running Laboratorios Farmacéuticos...
3 min
04/08/2023
ROVI informs on the evaluation process to obtain marketing authorisation for...
ROVI informs on the evaluation process to obtain marketing authorisation for Risvan® The United States Food and Drug Administration (...
1 min
28/07/2023
See More
Email
Facebook
Twitter
LinkedIn
Pantallazos-ROVI-4-1024x576(1).jpg